$IRMD News

IRADIMED CORPORATION to Hold Third Quarter 2026 Financial Results Conference Call on October 30, 2026

IRADIMED CORPORATION To Participate in the 5th Annual ROTH Healthcare Opportunities Conference

Needham Initiates Coverage On iRadimed with Hold Rating

IRadimed (IRMD) Q2 2026 Earnings Call Transcript

How IRADIMED's Modest Q2 Beat and Reaffirmed 2026 Guidance Will Impact IRMD Investors

Replacement Cycle Anchors IRadimed Corp.’s (IRMD) Long Term Growth

iRadimed Corp (IRMD) (Q2 2026) Earnings Call Highlights: Strong Demand for New 3,870 Pump ...

IRadimed Corporation Q2 2026 Earnings Call Summary

iRadimed Q2 Earnings Call Highlights

IRADIMED (NASDAQ:IRMD) Beats Q2 EPS, Reaffirms Full-Year Guidance

IRADIMED CORPORATION (IRMD) Q2 2026 Earnings Call Transcript

IRADIMED CORPORATION Reports Second Quarter 2026 Financial Results

iRadimed Sees Q3 Adj EPS $0.54-$0.59 vs $0.52 Est; Sees Sales $23.000M-$24.500M vs $23.650M Est

iRadimed Affirms FY2026 GAAP EPS Guidance of $1.90-$2.05 vs $1.91 Est

CORRECTION: iRadimed Raises FY2026 Adj EPS Guidance from $2.06-$2.21 to $2.09-$2.24 vs $2.08 Est; Affirms FY2026 Sales Guidance of $91.000M-$96.000M vs $91.300M Est

iRadimed Sees Q3 GAAP EPS $0.49-$0.54 vs $0.49 Est

Iradimed Corporation (IRMD) Sales Reflects The Fund’s Valuation and Sizing Discipline

IRADIMED CORPORATION to Hold Second Quarter 2026 Financial Results Conference Call on July 31, 2026

Assessing IRADIMED (IRMD) Valuation After Strong Multi Year Returns And A Premium P/E Multiple

IRADIMED's CEO Is Selling Steadily — The Plan, Not the Stock, Is Driving It